Cue Biopharma Inc (CUE) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Cue Biopharma Inc   (NASDAQ: CUE)

Cue Biopharma Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CUE Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 70.91 % 65.43 % 46.08 %
Gross Margin (Q2 TTM) 79.08 % 71.73 % 66.39 % 46.29 %
Gross Profit Margin 5 Yr. Avg. - 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) -0.18 % 22.25 % 19.59 % 20.47 %
EBITDA Margin (Q2 TTM) 42.16 % 25.28 % 20.86 % 20.12 %
EBITDA Margin 5 Yr. Avg. --1174.78 % 47.07 % 31.55 % 23.51 %
Operating Margin (Q2 MRQ) -1113.3 % 17.27 % 16.57 % 16.05 %
Operating Margin (Q2 TTM) -262.03 % 20.33 % 17.92 % 16.34 %
Operating Margin 5 Yr. Avg. --1212.06 % 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 13.66 % 10.93 % 13.96 %
Pre-Tax Profit Margin (Q2 TTM) 38.67 % 16.7 % 12.86 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.98 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) -1943.21 % 10.09 % 8.14 % 11.42 %
Net Margin (Q2 TTM) -435.83 % 13.13 % 9.99 % 10.76 %
Net Margin 5 Yr. Avg. - 5.79 % 6.08 % 10.8 %